• Probenecid in Neuroprotection: Mechanistic Depth and Experim

  2026-06-26

  Explore the multi-faceted biochemical actions of Probenecid (4-(dipropylsulfamoyl)benzoic acid) in neuroprotection and multidrug resistance reversal. This article delivers a deep mechanistic analysis and practical guidance for leveraging Probenecid in advanced research workflows.

• Cycloastragenol Inhibits Osteoclasts in Methylprednisolone-I

  2026-06-26

  This study establishes that cycloastragenol (CAG) effectively prevents bone loss in glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) by suppressing osteoclast activity in a rat model. The work provides mechanistic insight into osteoclast-targeted therapy for glucocorticoid-related bone disorders, highlighting practical research implications for translational bone disease models.

• Baicalin: KEAP1-NRF2/HO-1 Pathway Modulation in Research

  2026-06-25

  Baicalin is a flavone glycoside that modulates the KEAP1-NRF2/HO-1 pathway, supporting neuroplasticity and cancer research. It restores adult visual plasticity and sensitizes tumor cells to chemotherapy in preclinical models. This article details its mechanisms, evidence, and workflow integration for advanced research.

• Zishen Yutai Pills Reverse Cisplatin-Induced Ovarian Failure

  2026-06-25

  This study demonstrates that Zishen Yutai pills (ZYP) restore fertility in a mouse model of premature ovarian failure (POF) induced by cisplatin (CDDP), through modulation of arachidonic acid metabolism and the AKT pathway. The findings provide mechanistic and preclinical evidence for ZYP as a potential adjunct in fertility preservation during chemotherapy.

• Necrosulfonamide: Advancing Necroptosis Assays in Disease Mo

  2026-06-24

  Necrosulfonamide (NSA) from APExBIO sets the benchmark for MLKL-targeted necroptosis inhibition, enabling researchers to pinpoint cell death pathways with nanomolar precision. Its application streamlines necroptosis assays in cardiovascular, cancer, and neurodegenerative disease models—delivering robust, reproducible results where mechanistic clarity is essential.

• A40926: Dalbavancin Precursor Empowering Gram-Positive Resea

  2026-06-23

  A40926 stands out as a powerful dalbavancin precursor, delivering superior, reproducible performance in Gram-positive infection and MRSA research. This guide translates the latest regulatory and mechanistic findings into actionable protocol enhancements and troubleshooting strategies for in vitro and in vivo workflows.

• ARCA EGFP mRNA (5-moUTP): Next-Gen Polyadenylated mRNA Tools

  2026-06-23

  ARCA EGFP mRNA (5-moUTP) redefines polyadenylated mRNA workflows with robust fluorescence-based transfection control, superior mRNA stability, and minimized immunogenicity. Its optimized design streamlines experimental reproducibility and data confidence, unlocking advanced applications in mammalian cell research.

• Annexin V-PE Apoptosis Detection Kit: Rapid, Live-Cell Assay

  2026-06-22

  Leverage the Annexin V-PE Apoptosis Detection Kit for fast, fixation-free live-cell apoptosis quantification with minimal hands-on time and high sensitivity. This guide details optimized workflows, advanced applications, and troubleshooting strategies, empowering researchers to generate reliable cell death data in complex signaling studies.

• Benzyl Quinolone Carboxylic Acid: M1 Modulation for Cognitiv

  2026-06-22

  Benzyl Quinolone Carboxylic Acid (BQCA) empowers precise M1 muscarinic receptor potentiation, enabling researchers to dissect acetylcholine signaling and cognitive modulation in both in vitro and in vivo models. Leveraging new insights into GRK-mediated signaling bias, BQCA optimizes workflows for Alzheimer's disease and cognitive function research with high selectivity and reproducibility.

• Actinomycin D: Optimizing Transcriptional Inhibition in Canc

  2026-06-21

  Actinomycin D (ActD) stands at the forefront of transcriptional inhibition assays, enabling precision in apoptosis induction and mRNA stability studies. This guide details actionable protocols, workflow enhancements, and troubleshooting strategies to maximize data integrity and reproducibility when using APExBIO’s Actinomycin D.

• Angiotensin II–HIF-1α-HILPDA Axis Drives Ferroptosis and Rad

  2026-06-20

  This study elucidates how local angiotensin II, via the HIF-1α-HILPDA axis, suppresses ferroptosis and enhances radioresistance in nasopharyngeal carcinoma (NPC). The findings highlight molecular feedback mechanisms underlying treatment failure and suggest dual targeting of Ang II and ferroptosis for radiosensitization.

• Sodium Phosphate Dibasic: Precision Buffering for Modern Bio

  2026-06-19

  Explore the advanced role of sodium phosphate dibasic (Na2HPO4) as a precision buffering agent in contemporary biological assay design. This article reveals new insights into its impact on assay integrity, drawing on recent toxicological research and practical workflow guidance.

• E-64d in Apoptosis and Neuroprotection: Protocols & Insights

  2026-06-19

  E-64d, a membrane-permeable cysteine protease inhibitor, empowers researchers to dissect calpain- and cathepsin-dependent pathways in apoptosis, platelet function, and neuroprotection. This article translates the compound's advanced mechanistic leverage into stepwise workflows and practical troubleshooting, highlighting its unique advantages for both cellular and in vivo models.

• Lambda Protein Phosphatase (RNase-free): Precision in Circad

  2026-06-18

  Explore how Lambda Protein Phosphatase enables robust, high-specificity validation of phosphorylation events in circadian biology. This article uncovers advanced assay design strategies, bridging phase separation insights with practical workflows for protein phosphorylation studies.

• Amyloid Beta-Peptide (1-40): Applied Workflows & Innovations

  2026-06-18

  Amyloid Beta-Peptide (1-40) (human) elevates Alzheimer’s disease research with its reproducible modeling of amyloid aggregation, neurotoxicity, and microglial signaling. This guide distills recent mechanistic breakthroughs, optimized protocols, and troubleshooting insights that set APExBIO’s peptide apart for translational and mechanistic studies.

446 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page